<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background </plain></SENT>
<SENT sid="1" pm="."><plain>Mobilization of c-Kit(+) hematopoietic cells (HCs) contributes to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> vascularization </plain></SENT>
<SENT sid="2" pm="."><plain>Whereas survival and proliferation of HCs are regulated by binding of the stem cell factor to its receptor c-Kit, migration of HCs is directed by stromal cell-derived factor (SDF)-1 </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, targeting migration of HCs provides a promising new strategy of anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Methods </plain></SENT>
<SENT sid="5" pm="."><plain>BALB/c mice (n = 16) were pretreated with an anti-c-Kit antibody followed by implantation of CT26.WT-GFP <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells into dorsal skinfold chambers </plain></SENT>
<SENT sid="6" pm="."><plain>Animals (n = 8) additionally received a neutralizing anti-SDF-1 antibody </plain></SENT>
<SENT sid="7" pm="."><plain>Animals (n = 8) treated with a control antibody served as controls </plain></SENT>
<SENT sid="8" pm="."><plain>Investigations were performed using intravital fluorescence microscopy, immunohistochemistry, flow cytometry and western blot analysis </plain></SENT>
<SENT sid="9" pm="."><plain>Results </plain></SENT>
<SENT sid="10" pm="."><plain>Blockade of c-Kit significantly enhanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell engraftment compared to controls due to stimulation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation and invasion without markedly affecting <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> vascularization </plain></SENT>
<SENT sid="11" pm="."><plain>C-Kit blockade significantly increased VEGF and CXCR4 expression within the growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Neutralization of SDF-1 completely antagonized this anti-c-Kit-associated <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> by suppression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> neovascularization, inhibition of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation and reduction of muscular infiltration </plain></SENT>
<SENT sid="13" pm="."><plain>Conclusion </plain></SENT>
<SENT sid="14" pm="."><plain>Our study indicates that bone marrow suppression via anti-c-Kit pretreatment enhances <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell engraftment of colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> due to interaction with the SDF-1/CXCR4 pathway which is involved in HC-mediated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
</text></document>